Open AccessSame-Day Bilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections: Experience of a Large Canadian Retina Center
Author(s) -
Verena R. Juncal,
Carolina L. M. Francisconi,
Filiberto Altomare,
David R. Chow,
Louis R. Giavedoni,
Rajeev H. Muni,
Alan R. Berger,
David T. Wong
Publication year - 2019
Publication title -
ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.639
H-Index - 60
eISSN - 1423-0267
pISSN - 0030-3755
DOI - 10.1159/000499115
Subject(s) - medicine , ranibizumab , aflibercept , bevacizumab , endophthalmitis , concomitant , intravitreal administration , ophthalmology , incidence (geometry) , adverse effect , surgery , retinal , chemotherapy , physics , optics
To evaluate the outcomes and complications of bilateral same-day intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom